Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium
暂无分享,去创建一个
Margaret A. Pericak-Vance | Marylyn D. Ritchie | Tricia A. Thornton-Wells | William S. Bush | Scott M. Dudek | Jonathan L. Haines | Lindsay A. Farrer | Gerard D. Schellenberg | Timothy J. Hohman | Richard Mayeux | Lan Jiang | Eden R. Martin | Eric S. Torstenson | J. Haines | M. Pericak-Vance | G. Schellenberg | W. Bush | R. Mayeux | E. Martin | L. Farrer | M. Ritchie | T. Hohman | A. Naj | T. Thornton-Wells | B. Kunkle | K. Brown-Gentry | Lan Jiang | S. Dudek | E. Torstenson | Adam Naj | Brian W. Kunkle | Kristin D. Brown-Gentry | Shubhabrata Mukherjee | S. Mukherjee
[1] H. Nakanishi,et al. Mutation analysis of the MYO7A and CDH23 genes in Japanese patients with Usher syndrome type 1 , 2010, Journal of Human Genetics.
[2] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[3] V Shane Pankratz,et al. Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions. , 2011, Journal of Alzheimer's disease : JAD.
[4] A. Smith,et al. Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer’s disease , 2004, Journal of Medical Genetics.
[5] P. Deloukas,et al. Interactions between PPAR-α and inflammation-related cytokine genes on the development of Alzheimer's disease, observed by the Epistasis Project. , 2012, International journal of molecular epidemiology and genetics.
[6] Ian F. Harrison,et al. Prazosin, an α1-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease , 2013, Neurobiology of Aging.
[7] S. Rivest,et al. The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer's disease , 2013, Front. Physiol..
[8] L. Fratiglioni,et al. Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.
[9] P. Deloukas,et al. Interaction of insulin and PPAR-α genes in Alzheimer’s disease: the Epistasis Project , 2012, Journal of Neural Transmission.
[10] C. Jack,et al. Alzheimer's Disease Neuroimaging Initiative , 2008 .
[11] Jun Wang,et al. Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction* , 2006, Journal of Biological Chemistry.
[12] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[13] Diana Wang,et al. SIRT1 Suppresses b-Amyloid Production by Activating the a-Secretase Gene ADAM10 , 2010 .
[14] Tim Becker,et al. INTERSNP: genome-wide interaction analysis guided by a priori information , 2009, Bioinform..
[15] Richard J. Caselli,et al. Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers , 2011, NeuroImage.
[16] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[17] S. Nishio,et al. Prevalence and Clinical Features of Hearing Loss Patients with CDH23 Mutations: A Large Cohort Study , 2012, PloS one.
[18] R. Petersen,et al. Investigation of 15 of the top candidate genes for late-onset Alzheimer’s disease , 2010, Human Genetics.
[19] Winnie S. Liang,et al. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. , 2007, Neuron.
[20] Carlos Cruchaga,et al. The epigenetic landscape of Alzheimer's disease , 2014, Nature Neuroscience.
[21] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[22] O. Combarros,et al. Interaction between dopamine β-hydroxylase and interleukin genes increases Alzheimer’s disease risk , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[23] Timothy J. Hohman,et al. Epistatic Genetic Effects among Alzheimer’s Candidate Genes , 2013, PloS one.
[24] R. Lakshmy,et al. MTHFR (677 and 1298) and IL-6-174 G/C genes in pathogenesis of Alzheimer's and vascular dementia and their epistatic interaction , 2012, Neurobiology of Aging.
[25] M. Owen,et al. Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[26] G. Annoni,et al. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer’s disease , 2004, Neurobiology of Aging.
[27] L. Guarente,et al. RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10 , 2010, Cell.
[28] H. Kroemer,et al. MDR1‐P‐Glycoprotein (ABCB1) Mediates Transport of Alzheimer’s Amyloid‐β Peptides—Implications for the Mechanisms of Aβ Clearance at the Blood–Brain Barrier , 2007, Brain pathology.
[29] P. Crane,et al. Alzheimer’s Disease: Analyzing the Missing Heritability , 2013, PloS one.
[30] D. G. Clark,et al. Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.
[31] P. Sham,et al. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases , 2011, Genetic epidemiology.
[32] P. Deloukas,et al. The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project , 2010, BMC Medical Genetics.
[33] Marylyn D. Ritchie,et al. Genomic analyses with biofilter 2.0: knowledge driven filtering, annotation, and model development , 2013, BioData Mining.
[34] A. Dudarewicz,et al. Genetic Variants of CDH23 Associated With Noise-Induced Hearing Loss , 2014, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
[35] Winnie S. Liang,et al. GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers , 2007, Neuron.
[36] Eric M Reiman,et al. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. , 2007, Archives of neurology.
[37] L. Baki,et al. Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[38] A. Gambardella,et al. Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer’s disease , 2013, Journal of Neural Transmission.
[39] P. Riekkinen,et al. Effects of combined block of alpha 1-adrenoceptors and NMDA receptors on spatial and passive avoidance behavior in rats. , 1996, European journal of pharmacology.
[40] Zhiqiang Wang,et al. Emerging Roles of SIRT1 in Cancer Drug Resistance. , 2013, Genes & cancer.
[41] L. Y. Wang,et al. ABCB1 Genotype and CSF β-Amyloid in Alzheimer Disease , 2011, Journal of geriatric psychiatry and neurology.
[42] Shashwath A Meda,et al. Genetic interactions within inositol-related pathways are associated with longitudinal changes in ventricle size. , 2013, Journal of Alzheimer's disease : JAD.
[43] Michael Boehnke,et al. LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..
[44] Tricia A. Thornton-Wells,et al. Genetic interactions found between calcium channel genes modulate amyloid load measured by positron emission tomography , 2013, Human Genetics.
[45] Marylyn D. Ritchie,et al. Pacific Symposium on Biocomputing 14:368-379 (2009) BIOFILTER: A KNOWLEDGE-INTEGRATION SYSTEM FOR THE MULTI-LOCUS ANALYSIS OF GENOME-WIDE ASSOCIATION STUDIES * , 2022 .
[46] D. Stephan,et al. Genetic control of human brain transcript expression in Alzheimer disease. , 2009, American journal of human genetics.